We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Fujirebio Diagnostics Announces Initiation of Clinical Testing for SARS CoV-2 Antigen Assay

Product News   Aug 05, 2020

 
Fujirebio Diagnostics Announces Initiation of Clinical Testing for SARS CoV-2 Antigen Assay

Credit: KUTTHALEEYO/rawpixel

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Viral Transport Media by PrimeStore® MTM Evaluated by Public Health England for SARS-CoV-2 Inactivation

Product News

EKF Diagnostics new viral transport media PrimeStore® MTM (Molecular Transport Medium) has been successfully evaluated for effective SARS-CoV-2 inactivation. Currently, samples require the use of high-containment laboratories to be studied safely. Inactivation allows for a higher rate of testing within more laboratories.

READ MORE

SARS-CoV-2 Assay for BD Veritor™ Plus System Available in Europe By End of October

Product News

BD has announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has been CE marked to the IVD Directive (98/79/EC).BD plans to produce 8 million SARS-CoV-2 antigen tests per month by October and 12 million tests per month by March 2021.

READ MORE

REGN-COV2 Antibody Cocktail Reduced Viral Load and Alleviated Symptoms in Non-Hospitalized COVID-19 Patients

Product News

Regeneron has announced the first data from a descriptive analysis of a Phase 1/2/3 trial of the investigational antibody cocktail known as "REGN-COV2". Results show that it reduced viral load and alleviated symptoms in non-hospitalized patients with COVID-19.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE